Hub71+ Life Sciences: Advancing Healthcare Innovation in Abu Dhabi

The Middle East is experiencing a healthcare transformation, and Abu Dhabi is leading the charge. With the launch of Hub71+ Life Sciences, the UAE capital has unveiled its most ambitious initiative yet to accelerate innovation across biotechnology, MedTech, and digital health sectors. This specialist ecosystem represents a strategic step towards positioning Abu Dhabi as a global hub for innovative healthcare solutions.

The Growing Opportunity in Life Sciences

The timing couldn't be more strategic. The Middle East and Africa life sciences market was valued at $4.47 billion in 2024 and is projected to reach $5.04 billion in 2025, according to recent market analysis. This growth trajectory, combined with the region's increasing focus on healthcare diversification, creates an unprecedented opportunity for innovative startups.

"The UAE is making strategic investments and forming public-private partnerships to attract scientists and biotech companies," notes a recent industry report. This national commitment, combined with Hub71's proven track record of nurturing over 390 startups that have collectively raised AED 9 billion and generated AED 5 billion in revenue, creates a strong foundation for life sciences innovation.

What Makes Hub71+ Life Sciences Different

Hub71+ Life Sciences connects startups directly to Abu Dhabi's integrated health innovation cluster. It brings together policy support, research infrastructure, capital networks and clinical partnerships to create an environment where founders can pilot, validate and scale new solutions faster. The structured three-month guided track serves as one of several entry points into the ecosystem. The programme offers:

Financial Support That Scales

• AED 250,000 in in-kind incentives covering essential support services
• AED 250,000 in cash funding through a SAFE note
• Additional AED 250,000 top-up funding for high-performing startups
• Access to Hub71's network of 40+ capital partners

Regulatory Advantages

Operating within Abu Dhabi Global Market (ADGM), startups benefit from:

• Streamlined regulatory pathways for healthcare innovations
• Regulatory sandboxes for emerging technologies
• Direct access to UAE's progressive healthcare policies
• Simplified licensing for international expansion

Strategic Partnerships

The ecosystem connects startups with:

• Leading regional and global healthcare institutions
• Government health authorities for pilot programs
• Research institutions for clinical collaboration
• Corporate partners for market validation and scaling

The Precision Medicine Revolution

A core focus of Hub71+ Life Sciences is advancing precision medicine and genomics. The UAE continues to invest in genomic technologies, recognising their potential to transform patient care through personalised treatment approaches.

Recent healthcare reports indicate that genomic technologies are transforming patient care and advancing the fields of personalised and precision medicine. This focus aligns with global healthcare trends, as the precision medicine market continues to expand steadily worldwide. For startups working in areas such as:

• Genomic diagnostics and liquid biopsy technologies
• AI-powered drug discovery and development
• Personalised treatment platforms
• Digital therapeutics and remote monitoring

Hub71+ Life Sciences provides the perfect launchpad to access regional markets while building globally scalable solutions.

Market Access and Growth Potential

The Middle East life sciences market was valued at $2.40 billion in 2024 and is projected to reach $4.28 billion by 2033, reflecting steady long-term growth.

This growth is driven by:

• Increased healthcare expenditure across GCC countries
• A growing focus on preventive and personalised medicine
• Government initiatives supporting healthcare innovation
• The rising prevalence of chronic diseases requiring advanced treatments

For life sciences startups, this represents a regional opportunity and a gateway to global markets. Abu Dhabi's strategic location provides access to more than two billion people across Africa, Asia and Europe within an eight-hour flight radius.Early Momentum in Life Sciences

While Hub71+ Life Sciences is newly launched, the broader Hub71 ecosystem has already demonstrated remarkable success in healthcare innovation. In 2025, life sciences companies in the Middle East raised $355 million in equity funding across 19 rounds, reflecting strong investor confidence in the sector.

The programme builds on Hub71's proven model, which has helped startups across various sectors achieve:

• Record-breaking funding rounds
• Successful international expansion
• Strategic partnerships with global corporations
• Regulatory approvals in multiple markets

The Application Process: Your Gateway to Innovation

Getting started with Hub71+ Life Sciences is designed to be straightforward yet thorough. The programme seeks startups that are:

• Pre-seed to Series A stage with proven traction
• Developing breakthrough solutions in biotech, MedTech, or digital health
• Ready to scale in Middle Eastern and global markets
• Committed to Abu Dhabi as their regional headquarters

The selection process evaluates not just the technology and market potential, but also the team's capability to execute and scale within the unique opportunities that Abu Dhabi ecosystem provides.

Beyond Funding: The Ecosystem Advantage

What truly sets Hub71+ Life Sciences apart is the comprehensive ecosystem support that extends well beyond financial investment:

Clinical Trial Access

Startups gain access to clinical trial opportunities within the UAE's advanced healthcare network, enabling faster validation and regulatory approvals.

Access to Talent

Connection to top-tier talent from leading regional universities and international recruitment networks, supports founders in building world-class life sciences teams.

Market Intelligence

Comprehensive insights into regional healthcare needs, regulatory frameworks, and market dynamics help startups navigate their growth journey effectively.

Global Connectivity

Hub71's international partner network provides access to partnerships, investors and expansion opportunities across key global markets.

The Future of Healthcare Innovation

As we look toward 2025 and beyond, several trends are shaping the future of healthcare innovation:

• AI-driven diagnostics becoming mainstream in clinical practice
• Telemedicine and remote monitoring expanding access to care
• Personalised medicine moving from research to routine treatment
• Digital therapeutics gaining regulatory approval and market acceptance

Hub71+ Life Sciences is positioned to be at the forefront of these developments, providing startups with the resources and support needed to turn breakthrough innovations into market-ready solutions.

A Strategic Investment in the Future

The launch of Hub71+ Life Sciences marks a long-term investment in the future of healthcare. By connecting policymakers, investors, corporates, research institutions and entrepreneurs, Abu Dhabi is creating the conditions for innovation that will benefit not only the region but the wider world.

For life sciences entrepreneurs aiming to make a global impact, Abu Dhabi offers a collaborative environment designed to accelerate healthcare innovation and scale solutions globally.

Ready to Transform Healthcare?

Hub71+ Life Sciences is now accepting applications from innovative startups ready to revolutionise healthcare from Abu Dhabi. With comprehensive support, strategic partnerships, and access to one of the world's most dynamic markets, the programme equips founders to turn breakthrough ideas into global success stories.

The future of healthcare innovation is being written in Abu Dhabi. Will your startup be part of the story?

Click here to join the Hub71+ Life Sciences ecosystem.